Comparative Characteristics of Clinical, Radiological and Laboratory Data in Patients with Pulmonary Mycobacteriosis Caused by M. avium, M. kansasii
https://doi.org/10.58838/2075-1230-2026-104-1-58-64
Abstract
The objective: to identify specific clinical, radiological, and laboratory changes in the patients with pulmonary mycobacteriosis caused by M. avium or M. kansasii.
Subjects and Methods. An open retrospective cohort study was conducted. Examinations of 102 patients with confirmed pulmonary mycobacteriosis caused by M. avium or M. kansasii were analyzed. Among those examined, 79 (77.5%) were women and 23 (22.5%) were men. The age of patients ranged from 21 to 86 years old, the average age was 54.2 ±14.64 years old. All patients included in the study had newly detected changes in the lungs (foci, dissemination, and cavities); during the examination patients’ history was collected, and a physical examination was performed.
Results. In pulmonary MB caused by M. kansasii, a cavitary radiological form was typical – 66.6% versus 16.6% for MB caused by M. avium (p<0.05); in MB caused by M. avium, the bronchiectatic form developed in 53% versus 22.7% for MB caused by M. kansasii (p<0.05). In 63.4% of cases, the intoxication syndrome prevailed among clinical signs of MB. Concomitant pathology was reported in MB cases caused by M. avium in 68.1% versus 31.8% cases caused by M. kansasii (p<0.05). The absence of concomitant diseases in pulmonary MB was reported in 63.8% of cases caused by M. kansasii versus 38.8% caused by M. avium (p<0.05). In MB, the ventilation capacity of the lungs was often impaired according to the obstructive type.
About the Authors
A. D. Egorova
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Anna D. Egorova, Junior Researcher of Center for Respiratory Diseases Diagnosis and Rehabilitation
2 Yauzskaya Alleya, Moscow, 107564;
Phone: +7 (499) 785-90-26
A. S. Zaytseva
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Anna S. Zaytseva, Candidate of Medical Sciences, Senior Researcher, Head of Department № 4 for Tuberculosis Differential Diagnostics and In Vitro Treatment Methods
2 Yauzskaya Alleya, Moscow, 107564;
Phone: +7 (499) 785-90-26
N. L. Karpina
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Nataliya L. Karpinaб Doctor of Medical Sciences, Deputy Director for Research, Head of Center for Respiratory Diseases Diagnosis and Rehabilitation
2 Yauzskaya Alleya, Moscow, 107564;
Phone: +7 (499) 785-90-26
E. A. Shergina
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Elena A. Shergina, Candidate of Medical Sciences, Head of Funcional Diagnosis Department, Center for Respiratory Diseases Diagnosis and Rehabilitation
2 Yauzskaya Alleya, Moscow, 107564;
Phone: +7 (499) 785-90-26
R. B. Amansakhedov
Central Tuberculosis Research Institute
Russian Federation
Russian Federation
Rasulguly B. Amansakhedov, Doctor of Medical Sciences, Senior Researcher, Head of of X-Ray Diagnosis Department, Center for Respiratory Diseases Diagnosis and Rehabilitation
2 Yauzskaya Alleya, Moscow, 107564;
Phone: +7 (499) 785-90-26
References
1. Amansakhedov R.B., Dmitrieva L.I., Smirnova T.G. et al. Radiological semiotics of different types of nontuberculous pulmonary mycobacterioses. Journal of Radiology and Nuclear Medicine, 2022, vol. 103, no. 1-3, pp. 30-37. (In Russ.) https://doi.org/10.20862/0042-4676-2022-103-1-3-30-37
2. Anisimova A.I., Gavrilov P.V., Pavlova M.V. et al. Clinical radiologic and species characterisation of mycobacterial infection. Meditsinsky Alyans, 2019, no. S3, pp. 26-27. (In Russ.)
3. Borisova O.V., Mordyk A.V. Epidemiology, clinical signs, diagnosis and treatment of mycobacteriosis. Meditsinsky Alyans, 2019, no. 2, pp. 35-45. (In Russ.)
4. Guntupova L.D., Borisov S.E. Pulmonary mycobacterioses in the megapolis: management, treatment outcomes, follow-up. CTRI Bulletin, 2021, no. 1, pp. 38-49. (In Russ.) https://doi.org/10.7868/S2587667821010052
5. Guntupova L.D., Borisov S.E., Solovyova I.P. et al. Mycobacterioses in phthisiopulmonary practice: literature review and personal experience. Prakticheskaya Meditsina, 2011, vol. 50, no. 3-1, pp. 39-50. (In Russ.)
6. Zimina V.N., Degtyareva S.Yu., Beloborodova E.N., Kulabukhova E.I., Rusakova L.I., Fesenko O.V. Mycobacterioses: the current state of the problem. Clinical Microbiology and Antimicrobial Chemotherapy, 2017, vol. 19, no. 4, pp. 276-282. (In Russ.)
7. Karpina N.L., Asanov R.B., Shishkina E.R. Clinical and microbiological aspects of diagnosis of non-tuberculosis mycobacteriosis in lung cavities. CTRI Bulletin, 2020, no. 4, pp. 73-80. (In Russ.) https://doi.org/10.7868/S2587667820040081
8. Makarova M.V., Guntupova L.D. Non-tuberculous mycobacteria. BIOpreparaty, Profilaktika, Diagnostika, Lechenie, 2020, vol. 20, no. 2, pp. 97-102. (In Russ.) https://doi.org/10.30895/2221-996X-2020-20-2-97-102
9. Sargsyan A.P., Makaryants N.N., Lepekha L.N., Chernousova L.N. Clinical and radiological manifestations of mycobacteriosis in patients with chronic lung diseases. Doktor.Ru, 2021, vol. 20, no. 7, pp. 66-72. (In Russ.) https://doi.org/10.31550/1727-2378-2021-20-7-66-72
10. Smirnova T.G., Andreevskaya S.N., Larionova E.E., Andrievskaya I.Yu., Ustinova V.V., Chernousova L.N. Monitoring of species diversity of non-tuberculosis mycobacteria in the some Russian regions using DNA-strips of GenoType Mycobacterium CM/AS (HAIN LIFESCIENCE, Germany). Tuberculosis and Lung Diseases, 2017, vol. 95, no. 5, pp. 54-59. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-5-54-59
11. Shmelev E.I., Zaytseva A.S., Makaryants N.N. et al. Patients with non-tuberculous mycobacteriosis in clinical practice. Pulmonologiya, 2022, vol. 32, no. 1, pp. 95-102. (In Russ.) https://doi.org/10.18093/0869-0189-2022-32-1-95-102
12. Adjemian J., Daniel-Wayman S., Ricotta E., Prevots D.R. Epidemiology of nontuberculous mycobacteriosis. Semin. Respir. Crit. Care Med., 2018, vol. 39, no. 3, pp. 325-335. https://doi.org/10.1055/s-0038-1651491
13. Bruno Ali, Lopez-Luis B.A., Sifuentes-Osornio J. et al. Nontuberculous mycobacterial infection in a tertiary care center in Mexico, 2001-2017. Braz. J. Infect. Dis., 2020, vol. 24, no. 3, pp. 213-220. https://doi.org/10.1016/j.bjid.2020.04.012
14. Chin-Chung Shu, Ming-Fang Wu, Sheng-Wei Pan, Ting-Shu Wu, Hsin-Chih Lai, Meng-Chih Lin. Host immune response against environmental nontuberculous mycobacteria and the risk populations of nontuberculous mycobacterial and the risk populations of nontuberculous mycobacterial lung disease. Journal of the Formosan Medical Association, 2020, vol. 119, suppl. 1, pp. S13-S22. https://doi.org/10.1016/j.jfma.2020.05.001
15. Cowman S., van Ingen J., Griffith D.E., Loebinger M.R. Non-tuberculous mycobacterial pulmonary disease. Eur. Respir. J., 2019, vol. 54, no. 1, pp. 1900250. https://doi.org/10.1183/13993003.00250-2019
16. Dahl V.N., Mølhave M., Fløe A., van Ingen J., Schön T., Lillebaek T., Andersen A.B., Wejse C. Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic review. Int. J. Infect. Dis., 2022, no. 125, pp. 120-131. https://doi.org/10.1016/j.ijid.2022.10.013
17. Daley C.L., Iaccarino J.M., Lange C., Cambau E., Wallace R.J. et al. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline. Clin. Infect. Dis., 2020, vol. 71, no. 4, pp. 905-913. https://doi.org/10.1093/cid/ciaa1125
18. De Marca P.G.C., Goldenberg T., Mello F.C.Q., Carvalho A.R.S., Guimarães A.R.M., Mogami R., Lopes A.J. Pulmonary densitovolumetry using computed tomography in patients with nontuberculous mycobacteria: correlation with pulmonary function tests. Pulm. Med., 2019, 2019, no. 3, pp. 5942783. https://doi.org/10.1155/2019/5942783
19. Haworth C.S., Banks J., Capstick T. et al. British Thoracic Society Guideline for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD). BMJ Open Respiratory Research, 2017, vol. 4, no. 1, pp. e000242. https://doi.org/10.1136/bmjresp-2017-000242
20. Jones M.M., Winthrop K.L., Nelson S.D., Duvall S.L., Patterson O.V., Nechodom K.E., Findley K.E., Radonovich L.J.Jr., Samore M.H., Fennelly K.P. Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration. PLoS One, 2018, vol. 13, no. 6, pp. e0197976. https://doi.org/10.1371/journal.pone.0197976
21. Prasla Z., Sutliff R.L., Sadikot R.T. Macrophage signaling pathways in pulmonary nontuberculous mycobacteria infections. Am. J. Respir. Cell. Mol. Biol., 2020, vol. 63, no. 2, pp. 144-151. https://doi.org/10.1165/rcmb.2019-0241TR
22. Sharma S.K., Upadhyay V. Epidemiology, diagnosis & treatment of non-tuberculous mycobacterial diseases. Indian J. Med. Res., 2020, vol. 152, no. 3, pp. 185-226. https://doi.org/10.4103/ijmr.IJMR_902_20
23. Standardization of Lung Function Tests. Report Working Party European Community for Steel and Coal. Official statement of European Respiratory Society. Eur. Respir. J., 1993, no. 6, pp. 1-121.
Review
For citations:
Egorova A.D., Zaytseva A.S., Karpina N.L., Shergina E.A., Amansakhedov R.B. Comparative Characteristics of Clinical, Radiological and Laboratory Data in Patients with Pulmonary Mycobacteriosis Caused by M. avium, M. kansasii. Tuberculosis and Lung Diseases. 2026;104(1):58-64. (In Russ.) https://doi.org/10.58838/2075-1230-2026-104-1-58-64
Views:
212
JATS XML
Email this article 